Context: Controlled ovarian stimulation induces morphological, biochemical, and functional genomic modifications of the human endometrium during the window of implantation.
supraphysiological levels of ovarian steroid hormones and paracrine mediators on the endometrium are minimal as a collateral effect. Despite advances in new stimulation protocols, pregnancy rates are still relatively low and have not significantly increased in the last decade (3, (5) (6) (7) , suggesting that the endometrium in controlled ovarian stimulation cycles is not an unaffected bystander.
Histological and immunohistochemical observations using window of implantation (WOI) markers have demonstrated endometrial modifications during the luteal phase in controlled ovarian stimulation compared with natural cycles (8) . In controlled ovarian stimulation, the luteal phase is abnormal compared with the natural cycle, and has characteristic features such as elevated progesterone concentrations during the early luteal phase, followed by a dramatic and premature decrease in the unsupported mid-luteal phase (9) . A morphological advancement in the early luteal phase of the endometrium in controlled ovarian stimulation cycles has been consistently reported in histological examination (10 -12) and scanning electron microscopy studies (13, 14) .
Supraphysiological concentrations of estradiol and subtle progesterone increases in the late follicular phase lead to a modulated steroid receptor profile resembling that of the early luteal phase (15) . Immunohistochemical studies have demonstrated a down-regulation of endometrial estradiol receptor and progesterone receptor (16) , and biochemical changes in the endometrial fluid (17) in controlled ovarian stimulation compared with natural cycles. Microarray studies comparing controlled ovarian stimulation with natural cycles in the same patient using agonist (18) or antagonist (19) protocols indicate a profound impact on the endometrial gene expression at implantation.
Different uncontrolled studies suggest that uterine receptivity diminishes during controlled ovarian stimulation used in ARTs compared with natural cycles (20, 21) . This deleterious effect on uterine receptivity has been reported as a mediated response, which is worse in high-responder patients to gonadotrophins (22) (23) (24) (25) .
Furthermore, it has been demonstrated that although low doses of estradiol maintain the receptive state of the endometrium, high doses cause it to become refractory in mice (26) .
In the present study, we have compared the global gene expression profiling across the WOI in natural vs. controlled ovarian stimulation cycles to elucidate the genomic impact of controlled ovarian stimulation on endometrial development and to search for novel gene targets to improve endometrial receptivity in IVF.
Patients and Methods

Study design and tissue collection
This study has been approved by the Ethics Committee of the Instituto Valenciano de Infertilidad, Valencia, Spain, the institution in which the endometrial biopsies were obtained and processed. Written informed consent was obtained from all patients.
Endometrial samples (n ϭ 50) were collected from healthy fertile cycling donors (aged 23-39 yr), with a body mass index of 19 -25 kg/m 2 , who underwent either natural cycles (n ϭ 25) or controlled ovarian stimulation treatment (n ϭ 25) consisting of a long protocol with leuprolide acetate and FSH/haptoglobin, human menopausal gonadotropin and human chorionic gonadotropin (hCG), as described previously (18) . Endometrial biopsies were obtained on days LHϩ1 (n ϭ 5), LHϩ3 (n ϭ 5), LHϩ5 (n ϭ 5), LHϩ7 (n ϭ 5), and LHϩ9 (n ϭ 5) in natural cycles, and at hCGϩ1 (n ϭ 5), hCGϩ3 (n ϭ 5), hCGϩ5 (n ϭ 5), hCGϩ7(n ϭ 5), and hCGϩ9 (n ϭ 5) in controlled ovarian stimulation cycles. In both cases no luteal phase supplementation was administered. All of them were obtained from different women.
In natural cycles a daily assessment of the urinary LH levels beginning on cycle d 10 was performed using a commercially available ovulation predictor kit (Donacheck ovulació n; Novalab Ibérica, S.A.L, Coslada, Madrid, Spain), and the day of the urinary LH surge was considered to be LHϭ0. Biopsies were obtained from the uterine fundus using a Pipelle catheter (Genetics, Namont-Achel, Belgium) under sterile conditions. Endometrial dating was performed using the criteria of Noyes et al. (27) by two different pathologists who were blinded to the day on which the specimen was obtained. The histological analysis was performed for endometrial biopsies in natural and controlled ovarian stimulation cycles. Only endometrial samples considered "in phase" were included in the present study for microarray interrogation. One of the samples corresponding to hCGϩ5 was excluded for microarray analysis due to its inconsistency with the histological dating.
Total RNA isolation and microarray hybridization
Endometrial samples were snap frozen in liquid nitrogen and stored at Ϫ70 C. Total RNA was extracted using the "TRIZOL method" according to the protocol recommended by the manufacturer (Life Technologies, Inc., Gaithersburg, MD). Approximately 1-2 mg total RNA was ob tained per mg endometrial tissue. RNA quality was assessed by loading 300 ng total RNA onto an RNA Labchip and was an-alyzed in an A2100 Bioanalyser (Agilent Technologies, Waldbronn, Germany). Hybridization onto Affymetrix HG-U133A chip (Affymetrix, Inc., Santa Clara, CA) was performed by Gene Logic an Ocimum Biosolutions Co. (Gaithersburg, MD) as described (28) .
Data analysis
Bioinformatics analysis
The microarray analysis was performed using the Gene Expression Pattern Analysis Suite (GEPAS) version 3.1, available at http://www. gepas.org (29) . The functional annotation of the analysis results was performed using the Babelomics suite, available at http://www. babelomics.org (30) .
Preprocessing
Output data from the microarray normalization process were preprocessed before performing the microarray analysis. Multiple probes mapping to the same gene were merged using the average as the summary of the hybridization values.
Sample clustering
Samples were grouped into clusters using a self-organizing neural network with tree topology, the Self-Organising Tree Algorithm (SOTA) algorithm (31) . We applied a euclidean distance and an unrestricted growth condition to obtain only one sample per cluster.
Differential gene expression
We applied a t test for the difference in the mean expression between two groups of arrays (classes). We compared expression patterns for samples at each time point (days) between the LH and hCG classes, obtaining P values for each gene in the experiment. We also applied a t test between the LHϩ1 and LHϩ7, and between the hCGϩ1 and hCGϩ7 sample sets. To account for multiple testing effects, we corrected the P values using the false discovery rate (32) .
Functional analysis of the results
To detect activations or deactivations in biological functions or pathways, we have used the FatiScan (33), a gene set based algorithm that detects significantly up-regulated or down-regulated blocks of functionally related genes in lists of genes ordered by differential expression. FatiScan is part of the Babelomics suite (30) . FatiScan can search blocks of genes functionally related by different criteria, such as gene ontology (GO) terms Kyoto Encyclopedia of Genes and Genomes pathways, and others.
Clustering of gene expression patterns
The SOTA method (31) was used to cluster expression profiles of both genes or samples. The SOTA is included in the GEPAS (29) . For the visualization and evaluation of the clusters' quality, we used Environment of Tree Exploration, a module of the GEPAS. Functional enrichment of the clusters was studied with the FatiGOϩ tool (34, 35) .
Microarray validation: quantitative-PCR and immunohistochemistry
To verify the results obtained from the cDNA microarray, real-time PCR was performed for four selected genes: IGF binding protein (IGFBP)-3; glutathione peroxidase-3 (GPX3); solute carrier family (SLC) 1 (neuronal/epithelial high-affinity glutamate transporter system Xag) member 1 (SLC1A1); and glycodelin (also known as placental protein 14). The relative expression levels of each gene in the total RNA from the endometrium was determined by real-time RT-PCR using specific primers for each gene: primer sequence (5Ј-3Ј) for IGFBP-3, forward 5Ј-GCACAGATACCCA-GAACTTCTCC and reverse 5Ј-CAGGTGATTCAGTGTGTCTTCCA; GPX3, forward 5Ј-CGATTTAGGTGACACTATAGCATGGGTG-TACAGCCACGTG and reverse 5Ј-CGTAATACGACTCACTATAG-GGGGGCCTTAGCCTGAATGCAC; SLC1A1, forward 5Ј-GTCCTG-ACTGGGCTTGCAA and reverse 5Ј-CAACGGGTAACACGAATCGA; and glycodelin, forward 5Ј-TGGTCTGTGGTGTCCCGG and reverse 5Ј-AGGGAGATGTTGTTGGTCGC.
Immunohistochemistry was performed, as previously described (36), for three selected genes at 3 different days of natural cycles: IGFBP-7, growth arrest and DNA damage inducible gene-45, and glycodelin (PP14). Microarray data validation (data not shown) has been presented to the reviewers.
Results
Cluster analysis
Principal component analysis (PCA) is a statistical method that allows projecting higher-dimensional data onto a lowerdimensional space. When PCA is applied to data, samples with similar trends in their gene expression profiles tend to cluster close together in the plot. Figure 1 shows clusters corresponding to the development of the endometrium in natural vs. stimulated cycles. Endometrial samples corresponding to LHϩ1 in natural cycles and to hCGϩ1 in stimulated cycles showed a very similar gene expression profile (Fig. 1, upper-right corner) . Similar results were obtained for LHϩ3 and hCGϩ3 ( Fig. 1 , right side), LHϩ5 and hCGϩ5, and LHϩ9 and hCGϩ9 ( Fig. 1 , upper-left corner). The only group that showed statistical differences in its gene profile corresponded to LHϩ7 in natural cycles vs. hCGϩ7 in stimulated cycles (Fig. 1 ). The exception was one LHϩ7 sample that segregated close to the hCGϩ7 cluster and was histologically classified as "in phase." Samples for LHϩ7 and LHϩ9 in natural cycles and hCGϩ9 in stimulated cycles showed very similar gene expression profiles at the receptive part.
Hierarchical clustering was also applied to the microarray gene expression profiles of the 49 well-characterized endometrial samples. The SOTA (31) was applied to the complete gene expression matrix to obtain a tree of the relationships among all the samples of the experiment. Similar results to the PCA were obtained (data not shown).
Temporal functional profiling in natural vs. controlled ovarian stimulation cycles along the WOI To understand how cellular functionalities are activated and deactivated along the WOI in natural vs. controlled ovarian stimulation cycles, we analyzed their corresponding temporal functional profiles. For that end, we used the first day as reference, and we compared each subsequent day with this reference time by a gene set enrichment analysis, as implemented in the FatiScan tool of Babelomics. This method allows us to trace the functional blocks (GO, Kyoto Encyclopedia ofGenesandGenomespathways,etc.)thatwere significantly up-regulated and down-regulated on each day of the WOI.
In Fig. 2 , we described overrepresented (A and C) and underrepresented (B and D) GO functions in natural vs. controlled ovarian stimulation cycles. Many overrepresented biological terms were shared in both natural and controlled ovarian stimulation categories, particularly on d ϩ3 and ϩ5, suggesting a similar development on the first days of the WOI. However, on d ϩ7 the natural cycle showed a higher number of overrepresented biological terms, such as "localization," "response to external stimulus," "locomotion," "response to biotic stimulus," and others ( Fig. 2A) . Interestingly, most of these GO terms are not present in the transition from day hCGϩ5 to hCGϩ7 in controlled ovarian stimulation cycles. Only two GO terms are conserved in the transition from the pre-receptive to receptive state in natural and controlled ovarian stimulation cycles; these terms are the "response to the stress" and "cellular physiological process."
We also found similarities in the biological terms underrepresented in the pre-receptive endometrium, except on d ϩ7 when more differences were observed. On d ϩ7 no common biological term was identified in natural and controlled ovarian stimulation cycles. Furthermore, some terms appeared to be underrepresented in hCGϩ7 of controlled ovarian stimulation cycles, such as response to external stimulus or organismal physiological process, which are overrepresented in LHϩ7 of natural cycles ( Fig. 2A) .
Differential gene expression between natural and controlled ovarian stimulation cycles
A t test was applied to each day's samples, which were grouped into two classes, LH and hCG, to find any significant difference in the gene expression patterns under these conditions. No significant differences were found between the LH and hCG gene expression profiles except in the LHϩ7/hCGϩ7 comparison, which showed a high number of significantly overexpressed and underexpressed genes in LHϩ7 vs. hCGϩ7. When genes differentially expressed (false discovery rate-adjusted P value Ͻ 0.01) were clustered using the SOTA, six main cluster expression profiles were found, three belonging to natural cycles and three to controlled ovarian stimulation cycles (Fig. 3) . In natural cycles, cluster 1 (Fig. 3A) was formed by 133 genes that were down-regulated at LHϩ7 and LHϩ9. Cluster 2 comprised 120 genes, and was homogeneous throughout the WOI, peaking at LHϩ3 and LHϩ5 (Fig. 3B) . Cluster 3 was the largest in the natural cycle with 218 genes and showed an up-regulation at LHϩ7 that was maintained at LHϩ9 (Fig. 3C) . In controlled ovarian stimulation cycles, cluster 1 was composed of 117 genes that maintained a similar profile from hCGϩ1 to hCGϩ7, and decreased at hCGϩ9 (Fig. 3D) . The 138 genes of cluster 2 displayed a clear peak at hCGϩ5 and hCGϩ7, and decreased thereafter (Fig. 3E) . Finally, cluster 3 was formed by 216 genes with no changes during the WOI until day hCGϩ9, when their expression suddenly increased (Fig. 3F) .
Interestingly, when we analyzed the list of genes of the different clusters, we found that 97 genes corresponding to 73% of the genes from cluster 1 in the natural cycle (Fig. 3A) were present in cluster 1 of controlled ovarian stimulation cycles (Fig. 3D) , and 104 genes (87%) of the cluster 2 in the natural cycle (Fig. 3B) were present in cluster 2 of controlled ovarian stimulation cycles (Fig. 3E) . Of the 218 genes of cluster 3 in the natural cycle (Fig.  3C) , 203 (93%) were included in cluster 3 of the controlled ovarian stimulation cycle (Fig. 3F) , and the expression peak of 203 genes underwent a 2-d delay in controlled ovarian stimulation vs. natural cycles (LHϩ7) (Fig. 3F) . Interestingly, an important number of the down-regulated and up-regulated genes of clusters A and C of natural cycle (27 and 74 genes, respectively) with a delayed expression are categorized as WOI genes (18) and listed in Table 1 . The overrepresented biological processes for these 97 down-regulated (cluster A) and 203 up-regulated (cluster C) delayed genes are listed in Table 2 . Therefore, all three clusters described present a 2-d delay in controlled ovarian stimulation vs. natural cycles only in the transition from the prereceptive to the receptive phase, demonstrating for the first time a molecular substrate for the impact of controlled ovarian stimulation in the human endometrium.
Finally, we analyzed the biological connections among the 97 down-regulated and 203 up-regulated delayed genes of clusters A and C in controlled ovarian stimulation cycles by String (http:// string.embl.de/), and we found that vascular endothelial growth factor (VEGF) and MAPK kinase 1 (MAP2K1) were in connection with a significant number of genes (Fig. 4) .
Discussion
Reproductive endocrinologists involved in IVF have been working worldwide for more than three decades with controlled ovarian stimulation protocols, largely ignoring their possible detrimental effects on endometrial receptivity. Clinical data have suggested a lower implantation rate in controlled ovarian stimulation compared with natural cycles (3, (5) (6) (7) . However, supporting scientific data in the human endometrium with functional implications have been scarce until now. This study provides the first comparative, genome-wide analysis in natural vs. controlled ovarian stimulation cycles across the WOI. As a result we have gained insight into functional genomics that may account for The number of genes in each biological term and the percentage and P valued for each one are represented.
different endometrial development in controlled ovarian stimulation vs. natural cycles.
The molecular signature of controlled ovarian stimulation cycles during the WOI differs from natural cycles Different studies have partially addressed the genomics of the human endometrium specifically during the WOI (37) (38) (39) (40) (41) or during the complete menstrual cycle (42, 43) . Nonetheless, the sequential molecular development of the endometrium during the WOI in natural cycles has not been previously reported. The first conclusion to be drawn from this work is that the development of the human endometrium follows a genetic program with a well-defined molecular transition from the pre-receptive (unable to accept the adhesion of the human blastocysts) to the receptive endometrium, which is comparable among the different subjects investigated.
In stimulated cycles the endometrial gene expression pattern is very similar to natural cycles during the WOI in the pre-receptive phase from hCGϩ1 to hCGϩ5 (Fig. 1) . This observation was confirmed using hierarchical clustering. However, the gene expression profile of the receptive endometrium in the controlled ovarian stimulation cycle at hCGϩ7 showed significant statistical differences compared with the natural cycle at LHϩ7 ( Fig. 1 ). These differences have been partially suggested previously by our laboratory (18, 19) . Nonetheless, no rigorous statistical determination had been performed until now. We have also analyzed the functional dynamics of the WOI in both natural vs. controlled ovarian stimulation cycles using the bioinformatics tools implemented in the GEPAS (29) and Babelomics (30) . In general, it is remarkable how most of the biological processes are overrepresented and not underrepresented in the natural transition from the pre-receptive to receptive endometrium in natural and controlled ovarian stimulation cycles (Fig. 2) . The development of the WOI is a biological event that is primarily induced by gene activation rather than gene inactivation or repression. We propose the term "transcriptional awakening process" in contrast to a term that produces down-regulation or gene repression, which we propose as the "transcriptional sleeping process." However, some differences can be found between natural and controlled ovarian stimulation cycles, specifically on d ϩ7, in which many overrepresented GO terms in natural cycles do not parallel in controlled ovarian stimulation cycles. Furthermore, some GO terms involving a response to external stimuli have an opposite regulation (Fig. 2 , A and D). These differences match the results obtained in sample clustering where the greatest differences were observed precisely on d ϩ7. Clearly, the comparison of the dynamics of biological roles up-regulated and down-regulated in LH vs. hCG conditions provide us good insights into their different features as systems.
Analysis of gene clustering reveals a delay in the development of the endometrium in controlled ovarian stimulation cycles
At the gene expression level, natural cycles can be differentiated into two phases in terms of gene expression patterns: prereceptive (LHϩ1 to LHϩ5) and receptive (LHϩ7 to LHϩ9). This feature does not occur in controlled ovarian stimulation cycles where the transition from LHϩ5 to LHϩ7 is not that evident, suggesting that the biological processes that take place in endometrial development follow different molecular ways, especially in reaching the receptive status in natural (LHϩ7) and stimulated cycles (hCGϩ7).
Because we know that this day is crucial for embryonic implantation, we directly compared the differences between LHϩ7 in the natural cycle and hCGϩ7 in controlled ovarian stimulation cycles. When we compared the data from LHϩ7 vs. hCGϩ7, we found that 241 genes were up-regulated, and 291 were downregulated with a P value less than 0.1 (69 and 73 up-regulated and down-regulated genes, respectively; P Ͻ 0.05). This is in agreement with two previously cited (18, 19) , in which a high number of genes was found to be differently expressed between natural and controlled ovarian stimulation cycles (GnRH agonists or antagonists) and in disagreement with a third one (44). These differences have been discussed in a recent review (45) . When we compared gene clusters, a delay in controlled ovarian stimulation vs. natural cycles was demonstrated. This is genuinely surprising because it indicates that a large number of WOI genes present a different behavior in controlled ovarian stimulation cycles at this time point. When we performed a GO analysis, we found that many proteins belonged to basic physiological pathways that are necessary for the normal development of cellular functions, at that phase of the endometrial cycle, such as cellular lipid, fructose 6-phosphate, carboxylic acid, organic acid, phosphorus, carboxylic acid, and phosphate metabolisms. Other biological processes in which those proteins were involved were related to the normal development of angiogenesis, blood vessel development, and morphogenesis, also important at the mid-luteal phase. And, finally, other genes were involved in the control of cell number such as negative regulation of cell proliferation, cell death, positive regulation of apoptosis, and positive regulation of programmed cell death. Cellular localization revealed a large amount of membrane proteins such as solute carriers (SLC1A1, SLC15A1, SLC15A2, SLC22A4, and SLC7A11) implicated in ion/molecules transport, and receptors such as RARRES3, MET, ITGA3, ITL6ST, and TRPC6, essential for signal transduction.
Receptiveness is a very active biological process involving a large number of genes in a coordinated manner. These results show that the endometrium in controlled ovarian stimulation cycles does not reach the receptive status in the same manner or, at least, at the same biological time. It also means that the cellular structure of the endometrium in controlled ovarian stimulation cycles could not be built at implantation. Obviously, this could be detrimental for the development of an optimal receptivity.
To understand the reasons for this dys-regulation, we analyzed the net of connections of delayed genes, demonstrating that VEGF and other genes such as MAP2K1 are in the middle of the regulation of a relevant number of genes (Fig. 4) . VEGF is an important signaling protein involved in both vasculogenesis and angiogenesis, crucial processes for normal endometrium development. Abnormal angiogenesis may contribute to several different endometrial-related pathologies, including endometrial cancer, endometriosis, menorrhagia, and breakthrough bleeding (reviewed in Ref. 46) . It has been also hypothesized that progesterone may modulate vascular permeability changes necessary for implantation by its actions on decidualized cells and VEGF (47) . On the other hand, MAP2K1 was also found in the central part of the gene network. This protein acts as an integration point for multiple biochemical signals, and it has been demonstrated to be involved specifically in the signaling pathways of the decidualization process in mice (48) .
The discovery of the overrepresented and underrepresented biological processes during the development of the WOI in natural and controlled ovarian stimulation cycles provides invaluable information about the events that take place in the endometrial tissue in reaching receptivity. In this sense, this study contains a very large amount of data and information involving events that occur at the gene, molecular, and structural levels in the human endometrium in two different situations. It allows us to know the biological differences with the WOIs that are clinically induced by hormones. On the one hand, this helps us to go deep into the knowledge of the complex process of endometrial receptivity, whereas, on the other hand, it represents a useful tool to correct the molecular impact of controlled ovarian stimulation treatments on the human endometrium. Furthermore, controlled ovarian stimulation may lead to differences in the timing of endometrial maturation compared with natural cycles (15) . This genomic delay may be of interest to define gene targets for the understanding of endometrial development under controlled ovarian stimulation and search for the optimal stimulation treatments that better mimic the gene expression profile of the natural cycle.
